Cytomx Thera (CTMX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Sales | 8,752 | 11,653 | 6,272 | 3,454 | 3,094 |
| Gross Profit | 8,752 | 11,653 | 6,272 | 3,454 | 3,094 |
| Operating Expenses | 34,125 | 20,267 | 20,502 | 18,370 | 17,352 |
| Operating Income | -25,373 | -8,614 | -14,230 | -14,916 | -14,258 |
| Other Income | 183 | 356 | 171 | 255 | 85 |
| Pre-tax Income | -25,190 | -8,258 | -14,059 | -14,661 | -14,173 |
| Income Tax | 26 | -1 | -26 | 1 | 3 |
| Net Income Continuous | -25,216 | -8,257 | -14,033 | -14,662 | -14,176 |
| Net Income | $-25,216 | $-8,257 | $-14,033 | $-14,662 | $-14,176 |
| EPS Basic Total Ops | -0.69 | -0.23 | -0.40 | -0.40 | -0.39 |
| EPS Basic Continuous Ops | -0.69 | -0.23 | -0.38 | -0.40 | -0.39 |
| EPS Diluted Total Ops | -0.69 | -0.23 | -0.40 | -0.40 | -0.39 |
| EPS Diluted Continuous Ops | -0.69 | -0.23 | -0.38 | -0.40 | -0.39 |
| EBITDA(a) | $-24,870 | $-8,016 | $-13,334 | $-14,034 | $-13,346 |